Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
US |
|
M
|
Master Style PCL
SET:MASTER
|
TH |
|
Banco Bilbao Vizcaya Argentaria SA
MAD:BBVA
|
ES |
|
A
|
Amadeus Fire AG
DUS:AAD
|
DE |
|
Digital Brands Group Inc
NASDAQ:DBGI
|
US |
|
A G Barr PLC
LSE:BAG
|
UK |
|
J
|
JCDecaux SE
SWB:DCS
|
FR |
|
Boeing Co
NYSE:BA
|
US |
|
Powersoft SpA
MIL:PWS
|
IT |
|
Eutelsat Communications SA
PAR:ETL
|
FR |
|
E
|
Eaton Corporation PLC
DUS:3EC
|
IE |
|
Freund Corp
TSE:6312
|
JP |
|
E
|
EDP Energias de Portugal SA
F:EDP
|
PT |
|
P
|
Precision Wires India Ltd
NSE:PRECWIRE
|
IN |
|
1st Source Corp
NASDAQ:SRCE
|
US |
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
D
|
DMCI Holdings Inc
XPHS:DMC
|
PH |
|
B
|
Bayerische Motoren Werke AG
F:BMW
|
DE |
|
ING Groep NV
AEX:INGA
|
NL |
|
F
|
Fission Uranium Corp
OTC:FCUUF
|
CA |
|
C
|
Campbell Soup Co
F:CSC
|
US |
|
Valero Energy Corp
NYSE:VLO
|
US |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
L
|
Louisiana-Pacific Corp
F:LP3
|
US |
Wall St Price Targets
AMPH Price Targets Summary
Amphastar Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for AMPH is 26.37 USD with a low forecast of 21.21 USD and a high forecast of 31.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AMPH's stock price target?
Price Target
26.37
USD
According to Wall Street analysts, the average 1-year price target for AMPH is 26.37 USD with a low forecast of 21.21 USD and a high forecast of 31.5 USD.
What is the Revenue forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
16%
The compound annual growth rate for Operating Income over the next 3 years is 16%.
What is the Net Income forecast for Amphastar Pharmaceuticals Inc?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 8 years is 4%.
